GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sawai Group Holdings Co Ltd (TSE:4887) » Definitions » Debt-to-EBITDA

Sawai Group Holdings Co (TSE:4887) Debt-to-EBITDA : 2.04 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Sawai Group Holdings Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sawai Group Holdings Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円31,667 Mil. Sawai Group Holdings Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円57,760 Mil. Sawai Group Holdings Co's annualized EBITDA for the quarter that ended in Dec. 2023 was 円43,756 Mil. Sawai Group Holdings Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 2.04.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Sawai Group Holdings Co's Debt-to-EBITDA or its related term are showing as below:

TSE:4887' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -3.57   Med: -0.74   Max: 2.37
Current: 2.37

During the past 2 years, the highest Debt-to-EBITDA Ratio of Sawai Group Holdings Co was 2.37. The lowest was -3.57. And the median was -0.74.

TSE:4887's Debt-to-EBITDA is ranked worse than
58.17% of 655 companies
in the Drug Manufacturers industry
Industry Median: 1.66 vs TSE:4887: 2.37

Sawai Group Holdings Co Debt-to-EBITDA Historical Data

The historical data trend for Sawai Group Holdings Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sawai Group Holdings Co Debt-to-EBITDA Chart

Sawai Group Holdings Co Annual Data
Trend Mar22 Mar23
Debt-to-EBITDA
-3.57 2.10

Sawai Group Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 1.67 2.68 2.53 2.11 2.04

Competitive Comparison of Sawai Group Holdings Co's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Sawai Group Holdings Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sawai Group Holdings Co's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sawai Group Holdings Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sawai Group Holdings Co's Debt-to-EBITDA falls into.



Sawai Group Holdings Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sawai Group Holdings Co's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(13034 + 60098) / 34879
=2.10

Sawai Group Holdings Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(31667 + 57760) / 43756
=2.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Sawai Group Holdings Co  (TSE:4887) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Sawai Group Holdings Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sawai Group Holdings Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sawai Group Holdings Co (TSE:4887) Business Description

Traded in Other Exchanges
Address
5-2-30, Miyahara, Yodogawa-ku, Osaka, JPN, 532-0003
Sawai Group Holdings Co Ltd is engaged in providing management support or guidance to domestic and foreign companies engaged in businesses related to medical and healthcare services, such as the manufacture and sale of pharmaceutical products and medical equipment, as well as various businesses incidental or related to the same.

Sawai Group Holdings Co (TSE:4887) Headlines

No Headlines